Rescue experiments further demonstrated that silencing STEAP2 reverses the tumor-suppressive effects induced by METTL3 overexpression, highlighting the METTL3-STEAP2 axis as a therapeutic target in PTC (97). Here, METTL3 is linked to neoplasm.